Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Monday Sep 12, 2022
Monday Sep 12, 2022
touchEXPERT OPINIONS for touchONCOLOGY
Listen to three experts describe the role of immune dysregulation in myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML), and summarize the rationale and available data for emerging immune-based therapeutic strategies. In a short panel discussion, they consider the possible impact these therapies may have on future clinical practice.
The experts
- Prof. Dr. med. Uwe Platzbecker — University Hospital Leipzig, Leipzig, Germany
- Prof. Agnieszka Wierzbowska — Medical University of Łódź, Copernicus Memorial Hospital, Łódź, Poland
- Prof. Valeria Santini — University of Florence, Florence, Italy
This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novartis. This activity is provided by touchIME.
For further information visit our website: touchONCOLOGY
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.